{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:12:24Z","timestamp":1788970344924,"version":"build-2803163510"},"reference-count":9,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/ehjqcco\/qcag126","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:58:44Z","timestamp":1786017524000},"source":"Crossref","is-referenced-by-count":0,"title":["From recognition to action: guideline-directed medical therapy in dystrophin-related cardiomyopathy"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3247-8853","authenticated-orcid":false,"given":"Juliana","family":"Levy","sequence":"first","affiliation":[{"name":"Stanford University School of Medicine Department of Medicine, , Palo Alto, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"2026090911060993800_qcag126-B1","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026090911060993800_qcag126-B2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcag088","article-title":"Heart failure guideline-directed medical therapy in young adults with dystrophin-related cardiomyopathy: the HOPE-MD registry","author":"Monzo","year":"2026","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026090911060993800_qcag126-B3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1017\/S1047951125000587","article-title":"Cardiac treatment for duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committee","volume":"35","author":"Esteso","year":"2025","journal-title":"Cardiol Young"},{"key":"2026090911060993800_qcag126-B4","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00246-025-03917-2","article-title":"Cardiac medication use in ACTION for duchenne muscular dystrophy cardiomyopathy","volume":"47","author":"Wittlieb-Weber","year":"2026","journal-title":"Pediatr Cardiol"},{"key":"2026090911060993800_qcag126-B5","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcag105","article-title":"Temporal changes in guideline-directed medical therapy score and clinical outcomes in patients with heart failure","author":"Tamura","year":"2026","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026090911060993800_qcag126-B6","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/ejhf.3267","article-title":"Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: first data from the TITRATE-HF study","volume":"26","author":"Malgie","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026090911060993800_qcag126-B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment\u2013inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2026090911060993800_qcag126-B8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/ejhf.3618","article-title":"Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC","volume":"27","author":"Skouri","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026090911060993800_qcag126-B9","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcag126\/70760044\/qcag126.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcag126\/70760044\/qcag126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:30:20Z","timestamp":1788967820000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article\/doi\/10.1093\/ehjqcco\/qcag126\/8767973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":9,"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcag126","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"qcag126"}}